These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Feasibility of PiB positron emission tomography/computed tomography for treatment monitoring with Tafamidis in a patient with transthyretin cardiac amyloidosis. Fujioka K; Norikane T; Takami Y; Yamamoto Y; Noma T; Nishiyama Y J Nucl Cardiol; 2024 Mar; 33():101816. PubMed ID: 38246259 [TBL] [Abstract][Full Text] [Related]
12. Comparison of 1-h with 3-h planar Saitou T; Aikawa T; Manabe O; Nagase A; Kudo T; Oyama-Manabe N Ann Nucl Med; 2023 Feb; 37(2):99-107. PubMed ID: 36352186 [TBL] [Abstract][Full Text] [Related]
13. [18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions. Genovesi D; Vergaro G; Giorgetti A; Marzullo P; Scipioni M; Santarelli MF; Pucci A; Buda G; Volpi E; Emdin M JACC Cardiovasc Imaging; 2021 Jan; 14(1):246-255. PubMed ID: 32771577 [TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of heart-to-mediastinum ratio in Ikoma T; Ohtani H; Ohno K; Iguchi K; Suwa K; Sawada M; Tanahashi Y; Sakamoto A; Saotome M; Ichikawa S; Goshima S; Maekawa Y J Nucl Cardiol; 2023 Aug; 30(4):1374-1381. PubMed ID: 36547805 [TBL] [Abstract][Full Text] [Related]
16. New quantitative indices of cardiac amyloidosis with Matsuda N; Otsuka H; Otani T; Azane S; Kunikane Y; Otomi Y; Ueki Y; Kubota M; Amano M; Yagi S; Sata M; Harada M Jpn J Radiol; 2023 Apr; 41(4):428-436. PubMed ID: 36449252 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of PET for detection of cardiac amyloidosis: A systematic review and meta-analysis. Kim SH; Kim YS; Kim SJ J Cardiol; 2020 Dec; 76(6):618-625. PubMed ID: 32682627 [TBL] [Abstract][Full Text] [Related]
19. Validation of the Kumamoto criteria for prediction of Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078 [TBL] [Abstract][Full Text] [Related]
20. 18F-fluoride PET/MR in cardiac amyloid: A comparison study with aortic stenosis and age- and sex-matched controls. Andrews JPM; Trivieri MG; Everett R; Spath N; MacNaught G; Moss AJ; Doris MK; Pawade T; van Beek EJR; Lucatelli C; Newby DE; Robson P; Fayad ZA; Dweck MR J Nucl Cardiol; 2022 Apr; 29(2):741-749. PubMed ID: 33000405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]